Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anniek van der Aalst

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
COPD|August 6, 2020
Decreased Risk of COPD Exacerbations in Obese PatientsLian Smulders, Anniek van der Aalst, Erik D E T Neuhaus, et al.
International Journal of Colorectal Disease|August 30, 2020
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse eventsVera E R Asscher, Quirine van der Vliet, Karen van der Aalst, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
COPD|August 6, 2020
Decreased Risk of COPD Exacerbations in Obese PatientsLian Smulders, Anniek van der Aalst, Erik D E T Neuhaus, et al.
International Journal of Colorectal Disease|August 30, 2020
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse eventsVera E R Asscher, Quirine van der Vliet, Karen van der Aalst, et al.
Pageof 1